Follow us on social media for our latest updates.
An international team of researchers led by Patrik Verstreken at VIB-KU Leuven has succeeded in reversing the effects of Tau, a protein implicated in over 20 different diseases, including Alzheimer’s disease.
Researchers from the University of Surrey, VIB-KU Leuven, University of Lille, and a number of other institutions examined DNA variations in 151,188 Europeans without diabetes, to determine whether genetic differences can explain the known gender differences in how well the body is able to manage blood sugar and insulin levels.
Researchers from the lab of Wim Versées (VIB-VUB) in collaboration with the team of Patrik Verstreken (VIB-KU Leuven) presents the three-dimensional structure of an enzyme involved in Parkinson’s disease, epilepsy, Alzheimer's disease, and Down syndrome.
Top research institutes from Germany, France, Belgium and the UK have formed a new alliance to combat neurodegenerative diseases. Their mission? Catalyzing a United Response in Europe to Neurodegenerative Diseases, or CURE-ND for short.
This year the ALS League, comes with a new challenge for De Warmste Week! One with which we can mark one of our points on our Bucket List!
Each year, Clarivate publishes a ‘highly cited researchers’ list recognizing pioneers in their field. This list contains researchers who have demonstrated significant influence through the publication of multiple papers, highly cited by their peers, during the last decade (2009-2019). No less than 19 VIB researchers are part of this highly acclaimed group of influential scientists.
A team of immunology experts at VIB, KU Leuven, UZ Leuven and ULB in Belgium and the Babraham Institute in the UK have come together study this diversity in COVID-19 responses. This understanding is crucial to guide the development of effective healthcare and ‘early-warning’ systems to identify and treat those at risk of a severe response
A research team led by Joris de Wit at the VIB-KU Leuven Center for Brain & Disease Research has uncovered new molecular players critical for the formation and function of neuronal circuits in the brain. Through proteomic profiling of a specific synapse in the hippocampus, they identified multiple uncharacterized synaptic cell surface proteins, including a new regulator of connectivity.
In this week’s edition of Science, researchers at VIB and the UK DRI highlight the need for a better understanding of the environmental and genetic risks of Alzheimer’s disease. Gene variants should be studied in the right cell types and in the right context, they argue, if we want to make progress in our search for effective therapies.
Every year on World Alzheimer's Day, the French organization: Fondation Recherche Alzheimer honors top European researchers who have made an important contribution to research into the disease. The prize for "most promising young researcher" is awarded this year to two young talents, including Renzo Mancuso: an Argentinian scientist affiliated to VIB and the universities of Leuven and Antwerp.